v2rayN怎么导入ssr
The GenapSys™ Sequencer is exceptionally accurate, incredibly scalable, and amazingly affordable.
SEE THE NEW SEQUENCER
v2rayN怎么导入ssr
GenapSys has developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable.
DISCOVER OUR TECHNOLOGYv2rayN怎么导入ssr
The GenapSys platform has been successfully demonstrated in a range of
applications that include targeted sequencing to elucidate
both germline and somatic mutations, as well as sequencing a range of small genomes.
SEE THE DATA
v2rayN怎么导入ssr
GenapSys Launches Sequencer in Asia Amid Deadly Coronavirus Outbreak and Announces $75 Million New Funding
Read more >
Webcast Link to GenapSys Presentation at the 38th Annual J.P. Morgan Healthcare Conference
Read more >